Application of molecular cytogenetic in the diagnosis of patients with congenital anomalies for the reduction of infant mortality

Abstract

Infant mortality due to congenital anomalies constitutes a major diagnostic challenge of pediatric hospital admissions. However, the classic cytogenetic analysis is not sufficient to explain all the abnormalities found at birth, making essential to adopt a more sensible method. The work will investigate patients with apparently normal karyotype and clinical phenotype using the techniques of in situ hybridization (FISH) and multiplex ligation-dependent probe amplification (MLPA). The introduction of these methods to SUS will enable an accurate diagnosis, a course of treatment and appropriate genetic counseling, which can significantly reduce the incidence of mortality and hospital costs. (AU)